Chemed Corporation (CHE)
Data as of Nov 3, 2:04 PM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
CHE key stats
CHE GlowScore: Quiet
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Chemed Corporation
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
What's moving CHE today
Updated November 3, 2026As of November 3, 2026, Chemed Corporation (CHE) stock slipped to $535.00, down 1.32% (-$7.18) versus the previous close. On the day, shares have traded between $532.00 and $548.27. That puts CHE in the upper third of its 52-week range of $365.21 to $562.24. Chemed Corporation operates in the services-home health care services space and carries a market capitalization of roughly $6.93 billion, with about 97.4K shares changing hands.
Latest CHE news
- Chemed Corporation to Present at the UBS 2026 Global Healthcare ConferenceYahoo Finance· Nov 2, 9:00 AM ETET
- CHE Q3 deep dive: VITAS and Roto-Rooter drive revenue growth, margin headwinds persistYahoo Finance· Oct 30, 5:39 PM ET
- Chemed (CHE) Looks Repriced As Raised Guidance And Margin Gains Lift The NarrativeYahoo Finance· Oct 30, 10:11 AM ET
- 5 insightful analyst questions from Chemed’s Q3 earnings callYahoo Finance· Oct 30, 5:15 AM ET
- Chemed (CHE) Stock Gets Fair Value Bump As Vitas Strength Offsets Roto ConcernsYahoo Finance· Oct 30, 12:30 AM ET
- What Chemed (CHE) Said on Its Q3 Earnings Callmarketbeat.com· Oct 29, 3:04 AM ET
- Chemed: Q3 Earnings SnapshotYahoo Finance· Oct 28, 2:34 PM ETAP
- LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasmstocktwits.com· Oct 28, 1:56 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want CHE headlines, alerts and AI research in one place? Create a free account →
CHE buzz on Stocktwits
300 watchers$CHE undiscovered breakout with 298 watchers
@STRelativeStrength· Oct 28, 2:20 PM ET
LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm $LH $CHE https://stocktwits.com/news/equity/markets/lh-stock-hits-record-levels-che-stock-surges-to-over-52-week-highs/cZU9V8bR9Gk
@StocktwitsNews· Oct 28, 1:56 PM ET
Chemed just upgraded at Jefferies, here's why - $CHE - https://thefly.com/CHE
@theflynews· Oct 28, 5:10 AM ET
$CHE Q3 revenue was 690.9 million dollars, up 10.6%, and adjusted EPS was 6.75 dollars, up 28.1%. VITAS did basically all of it. VITAS revenue rose 12.2% to 457.4 million dollars on 9.4% more days of care. Adjusted EBITDA ex Medicare Cap rose 31.4% to 92.5 million dollars, mar…
@KryptonResearch14· Oct 28, 3:07 AM ET
$CHE reported earnings after the close today. EPS beat estimates: $6.75 vs. $6.39 expected, according to Stock Meadow. What do you think?
@shoc24· Oct 27, 9:27 PM ET· Bullish
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
CHE Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on CHE
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.